Literature DB >> 7744913

Long-term results of proximal femoral replacement for non-neoplastic disorders.

A L Malkani1, J J Settecerri, F H Sim, E Y Chao, S L Wallrichs.   

Abstract

We reviewed retrospectively 50 consecutive total hip arthroplasties with proximal femoral replacement prostheses in 49 patients. All the patients had massive bone loss. There were 31 women and 18 men who had undergone a mean of 3.1 hip operations. At the last review, 15 patients had died and two had been lost to follow-up, so that 32 patients (33 hips) were available for assessment. The mean age of the patients at the time of the operation was 60.6 years. The mean length of clinical follow-up was 11.1 +/- 4 years, and mean radiographic follow-up was 7.6 +/- 3.2 years. The average preoperative Harris hip score was 46 +/- 13 points, which improved to 80 +/- 10 points after one year and to 76 +/- 16 points at the latest follow-up. The most frequent complication was dislocation, which occurred in 11 hips. Four femoral components and seven acetabular prostheses were revised because of aseptic loosening. With revision at the end point, survivorship after total hip arthroplasty with a proximal femoral replacement prosthesis was predicted to be 64% at 12 years. Although our preliminary results of hip salvage with a proximal femoral replacement prosthesis were encouraging, a longer follow-up has shown a higher rate of failure.

Entities:  

Mesh:

Year:  1995        PMID: 7744913

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  15 in total

1.  Radiographic assessment of distal femur cemented stems in tumor endoprostheses.

Authors:  R E Turcotte; N A Stavropoulos; J Toreson; M Alsultan
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-04-28

2.  Incidence and management of hip dislocation in tumour patients with a modular prosthesis of the proximal femur.

Authors:  Stephan E Puchner; Philipp T Funovics; Christian Hipfl; Martin Dominkus; Reinhard Windhager; Jochen G Hofstaetter
Journal:  Int Orthop       Date:  2014-05-29       Impact factor: 3.075

3.  Total hip replacement for proximal femoral tumours: our midterm results.

Authors:  V A Sokolovski; V P Voloshin; M D Aliev; V S Zubikov; S A Saravanan; D V Martynenko; D V Nisichenko; K N Strelnikov
Journal:  Int Orthop       Date:  2006-04-12       Impact factor: 3.075

4.  Proximal femoral replacement in the management of acute periprosthetic fractures of the hip: a competing risks survival analysis.

Authors:  Matthew Colman; Lisa Choi; Antonia Chen; Lawrence Crossett; Ivan Tarkin; Richard McGough
Journal:  J Arthroplasty       Date:  2013-07-12       Impact factor: 4.757

5.  Quality of life following proximal femoral replacement using a modular system in revision THA.

Authors:  Muhyeddine M Al-Taki; Bassam A Masri; Clive P Duncan; Donald S Garbuz
Journal:  Clin Orthop Relat Res       Date:  2011-02       Impact factor: 4.176

6.  Proximal femoral reconstructions with bone impaction grafting and metal mesh.

Authors:  Martín A Buttaro; Fernando Comba; Francisco Piccaluga
Journal:  Clin Orthop Relat Res       Date:  2009-03-18       Impact factor: 4.176

7.  Early results of the LPS™ limb preservation system in the management of periprosthetic femoral fractures.

Authors:  M Curtin; C Bryan; E Murphy; C G Murphy; W Curtin
Journal:  J Orthop       Date:  2016-10-25

8.  Revision total hip arthroplasty with a porous-coated modular stem: 5 to 10 years follow-up.

Authors:  Dror Lakstein; David Backstein; Oleg Safir; Yona Kosashvili; Allan E Gross
Journal:  Clin Orthop Relat Res       Date:  2009-06-16       Impact factor: 4.176

9.  Survival and outcomes of modular endoprosthetic reconstruction of the proximal femur for primary and non-primary bone tumors: Single institutional results.

Authors:  Charles A Gusho; Bishir Clayton; Nabil Mehta; Matthew W Colman; Steven Gitelis; Alan T Blank
Journal:  J Orthop       Date:  2021-05-07

10.  Two stage revision with a proximal femur replacement.

Authors:  Ralf Dieckmann; Tom Schmidt-Braekling; Georg Gosheger; Christoph Theil; Jendrik Hardes; Burkhard Moellenbeck
Journal:  BMC Musculoskelet Disord       Date:  2019-02-08       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.